{"pmid":32434806,"title":"Management of acute kidney injury in COVID-19.","text":["Management of acute kidney injury in COVID-19.","Acute kidney injury has been reported in as many as 29% of COVID-19 patients. Reported risk factors include elevated baseline serum creatinine, elevated blood urea nitrogen, acute kidney injury, proteinuria, and hematuria. Suspected causes include sepsis and acute tubular necrosis resulting from renal hypoperfusion, cytokine release syndrome, direct viral invasion, renal medullary hypoxia secondary to alveolar damage, rhabdomyolysis, and cardiorenal syndrome due to viral myocarditis.","Cleve Clin J Med","Hassanein, Mohamed","Thomas, George","Taliercio, Jonathan","32434806"],"abstract":["Acute kidney injury has been reported in as many as 29% of COVID-19 patients. Reported risk factors include elevated baseline serum creatinine, elevated blood urea nitrogen, acute kidney injury, proteinuria, and hematuria. Suspected causes include sepsis and acute tubular necrosis resulting from renal hypoperfusion, cytokine release syndrome, direct viral invasion, renal medullary hypoxia secondary to alveolar damage, rhabdomyolysis, and cardiorenal syndrome due to viral myocarditis."],"journal":"Cleve Clin J Med","authors":["Hassanein, Mohamed","Thomas, George","Taliercio, Jonathan"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32434806","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.3949/ccjm.87a.ccc034","e_drugs":["Creatinine","Nitrogen","Urea"],"topics":["Treatment"],"weight":1,"_version_":1667521393833541633,"score":9.490897,"similar":[{"pmid":32247631,"pmcid":"PMC7110296","title":"Kidney disease is associated with in-hospital death of patients with COVID-19.","text":["Kidney disease is associated with in-hospital death of patients with COVID-19.","In December 2019, a coronavirus 2019 (COVID-19) disease outbreak occurred in Wuhan, Hubei Province, China, and rapidly spread to other areas worldwide. Although diffuse alveolar damage and acute respiratory failure were the main features, the involvement of other organs needs to be explored. Since information on kidney disease in patients with COVID-19 is limited, we determined the prevalence of acute kidney injury (AKI) in patients with COVID-19. Further, we evaluated the association between markers of abnormal kidney function and death in patients with COVID-19. This was a prospective cohort study of 701 patients with COVID-19 admitted in a tertiary teaching hospital that also encompassed three affiliates following this major outbreak in Wuhan in 2020 of whom 113 (16.1%) died in hospital. Median age of the patients was 63 years (interquartile range, 50-71), including 367 men and 334 women. On admission, 43.9% of patients had proteinuria and 26.7% had hematuria. The prevalence of elevated serum creatinine, elevated blood urea nitrogen and estimated glomerular filtration under 60 ml/min/1.73m(2) were 14.4, 13.1 and 13.1%, respectively. During the study period, AKI occurred in 5.1% patients. Kaplan-Meier analysis demonstrated that patients with kidney disease had a significantly higher risk for in-hospital death. Cox proportional hazard regression confirmed that elevated baseline serum creatinine (hazard ratio: 2.10, 95% confidence interval: 1.36-3.26), elevated baseline blood urea nitrogen (3.97, 2.57-6.14), AKI stage 1 (1.90, 0.76-4.76), stage 2 (3.51, 1.49-8.26), stage 3 (4.38, 2.31-8.31), proteinuria 1+ (1.80, 0.81-4.00), 2+ approximately 3+ (4.84, 2.00-11.70), and hematuria 1+ (2.99, 1.39-6.42), 2+ approximately 3+ (5.56,2.58- 12.01) were independent risk factors for in-hospital death after adjusting for age, sex, disease severity, comorbidity and leukocyte count. Thus, our findings show the prevalence of kidney disease on admission and the development of AKI during hospitalization in patients with COVID-19 is high and is associated with in-hospital mortality. Hence, clinicians should increase their awareness of kidney disease in patients with severe COVID-19.","Kidney Int","Cheng, Yichun","Luo, Ran","Wang, Kun","Zhang, Meng","Wang, Zhixiang","Dong, Lei","Li, Junhua","Yao, Ying","Ge, Shuwang","Xu, Gang","32247631"],"abstract":["In December 2019, a coronavirus 2019 (COVID-19) disease outbreak occurred in Wuhan, Hubei Province, China, and rapidly spread to other areas worldwide. Although diffuse alveolar damage and acute respiratory failure were the main features, the involvement of other organs needs to be explored. Since information on kidney disease in patients with COVID-19 is limited, we determined the prevalence of acute kidney injury (AKI) in patients with COVID-19. Further, we evaluated the association between markers of abnormal kidney function and death in patients with COVID-19. This was a prospective cohort study of 701 patients with COVID-19 admitted in a tertiary teaching hospital that also encompassed three affiliates following this major outbreak in Wuhan in 2020 of whom 113 (16.1%) died in hospital. Median age of the patients was 63 years (interquartile range, 50-71), including 367 men and 334 women. On admission, 43.9% of patients had proteinuria and 26.7% had hematuria. The prevalence of elevated serum creatinine, elevated blood urea nitrogen and estimated glomerular filtration under 60 ml/min/1.73m(2) were 14.4, 13.1 and 13.1%, respectively. During the study period, AKI occurred in 5.1% patients. Kaplan-Meier analysis demonstrated that patients with kidney disease had a significantly higher risk for in-hospital death. Cox proportional hazard regression confirmed that elevated baseline serum creatinine (hazard ratio: 2.10, 95% confidence interval: 1.36-3.26), elevated baseline blood urea nitrogen (3.97, 2.57-6.14), AKI stage 1 (1.90, 0.76-4.76), stage 2 (3.51, 1.49-8.26), stage 3 (4.38, 2.31-8.31), proteinuria 1+ (1.80, 0.81-4.00), 2+ approximately 3+ (4.84, 2.00-11.70), and hematuria 1+ (2.99, 1.39-6.42), 2+ approximately 3+ (5.56,2.58- 12.01) were independent risk factors for in-hospital death after adjusting for age, sex, disease severity, comorbidity and leukocyte count. Thus, our findings show the prevalence of kidney disease on admission and the development of AKI during hospitalization in patients with COVID-19 is high and is associated with in-hospital mortality. Hence, clinicians should increase their awareness of kidney disease in patients with severe COVID-19."],"journal":"Kidney Int","authors":["Cheng, Yichun","Luo, Ran","Wang, Kun","Zhang, Meng","Wang, Zhixiang","Dong, Lei","Li, Junhua","Yao, Ying","Ge, Shuwang","Xu, Gang"],"date":"2020-04-06T11:00:00Z","year":2020,"_id":"32247631","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.kint.2020.03.005","keywords":["covid-19","acute kidney injury","in-hospital death","kidney disease","pneumonia"],"locations":["Wuhan","Hubei","China","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Nitrogen","Creatinine","Urea"],"topics":["Diagnosis"],"weight":1,"_version_":1666138492010233856,"score":318.96326},{"pmid":32327202,"pmcid":"PMC7194105","title":"Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China.","text":["Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China.","Although the respiratory and immune systems are the major targets of Coronavirus Disease 2019 (COVID-19), acute kidney injury and proteinuria have also been observed. Currently, detailed pathologic examination of kidney damage in critically ill patients with COVID-19 has been lacking. To help define this we analyzed kidney abnormalities in 26 autopsies of patients with COVID-19 by light microscopy, ultrastructural observation and immunostaining. Patients were on average 69 years (19 male and 7 female) with respiratory failure associated with multiple organ dysfunction syndrome as the cause of death. Nine of the 26 showed clinical signs of kidney injury that included increased serum creatinine and/or new-onset proteinuria. By light microscopy, diffuse proximal tubule injury with the loss of brush border, non-isometric vacuolar degeneration, and even frank necrosis was observed. Occasional hemosiderin granules and pigmented casts were identified. There were prominent erythrocyte aggregates obstructing the lumen of capillaries without platelet or fibrinoid material. Evidence of vasculitis, interstitial inflammation or hemorrhage was absent. Electron microscopic examination showed clusters of coronavirus particles with distinctive spikes in the tubular epithelium and podocytes. Furthermore, the receptor of SARS-CoV-2, ACE2 was found to be upregulated in patients with COVID-19, and immunostaining with SARS-CoV nucleoprotein antibody was positive in tubules. In addition to the direct virulence of SARS-CoV-2, factors contributing to acute kidney injury included systemic hypoxia, abnormal coagulation, and possible drug or hyperventilation-relevant rhabdomyolysis. Thus, our studies provide direct evidence of the invasion of SARSCoV-2 into kidney tissue. These findings will greatly add to the current understanding of SARS-CoV-2 infection.","Kidney Int","Su, Hua","Yang, Ming","Wan, Cheng","Yi, Li-Xia","Tang, Fang","Zhu, Hong-Yan","Yi, Fan","Yang, Hai-Chun","Fogo, Agnes B","Nie, Xiu","Zhang, Chun","32327202"],"abstract":["Although the respiratory and immune systems are the major targets of Coronavirus Disease 2019 (COVID-19), acute kidney injury and proteinuria have also been observed. Currently, detailed pathologic examination of kidney damage in critically ill patients with COVID-19 has been lacking. To help define this we analyzed kidney abnormalities in 26 autopsies of patients with COVID-19 by light microscopy, ultrastructural observation and immunostaining. Patients were on average 69 years (19 male and 7 female) with respiratory failure associated with multiple organ dysfunction syndrome as the cause of death. Nine of the 26 showed clinical signs of kidney injury that included increased serum creatinine and/or new-onset proteinuria. By light microscopy, diffuse proximal tubule injury with the loss of brush border, non-isometric vacuolar degeneration, and even frank necrosis was observed. Occasional hemosiderin granules and pigmented casts were identified. There were prominent erythrocyte aggregates obstructing the lumen of capillaries without platelet or fibrinoid material. Evidence of vasculitis, interstitial inflammation or hemorrhage was absent. Electron microscopic examination showed clusters of coronavirus particles with distinctive spikes in the tubular epithelium and podocytes. Furthermore, the receptor of SARS-CoV-2, ACE2 was found to be upregulated in patients with COVID-19, and immunostaining with SARS-CoV nucleoprotein antibody was positive in tubules. In addition to the direct virulence of SARS-CoV-2, factors contributing to acute kidney injury included systemic hypoxia, abnormal coagulation, and possible drug or hyperventilation-relevant rhabdomyolysis. Thus, our studies provide direct evidence of the invasion of SARSCoV-2 into kidney tissue. These findings will greatly add to the current understanding of SARS-CoV-2 infection."],"journal":"Kidney Int","authors":["Su, Hua","Yang, Ming","Wan, Cheng","Yi, Li-Xia","Tang, Fang","Zhu, Hong-Yan","Yi, Fan","Yang, Hai-Chun","Fogo, Agnes B","Nie, Xiu","Zhang, Chun"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32327202","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.kint.2020.04.003","keywords":["covid-19","sars-cov-2","acute kidney injury","proteinuria","renal pathology"],"locations":["SARS-CoV","China"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Creatinine"],"topics":["Mechanism","Diagnosis"],"weight":1,"_version_":1666138494586585088,"score":262.37762},{"pmid":32479921,"title":"Kidney Infarction in Patients With COVID-19.","text":["Kidney Infarction in Patients With COVID-19.","Coronavirus disease 2019 (COVID-19) is a contagious, life-threatening infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Recent findings indicate an increased risk of acute kidney injury during COVID-19. The pathophysiological mechanisms leading to acute kidney injury in COVID-19 are unclear, but may include direct cytopathic effects of the virus on kidney tubular and endothelial cells, indirect damage caused by virus-induced cytokine release, and kidney hypoperfusion due to a restrictive fluid strategy. In this case-report we propose an additional pathophysiological mechanism. We describe two cases in which patients with COVID-19 developed a decrease in kidney function due to kidney infarction. These patients did not have atrial fibrillation. One of these patients was treated with therapeutic doses of low molecular weight heparin, whereafter no further deterioration of kidney function was observed. Our findings implicate that the differential diagnosis of acute kidney injury in COVID-19 patients should include kidney infarction, which may have important preventive and therapeutic implications.","Am J Kidney Dis","Post, Adrian","den Deurwaarder, Edwin S G","Bakker, Stephan J L","de Haas, Robbert J","van Meurs, Matijs","Gansevoort, Ron T","Berger, Stefan P","32479921"],"abstract":["Coronavirus disease 2019 (COVID-19) is a contagious, life-threatening infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Recent findings indicate an increased risk of acute kidney injury during COVID-19. The pathophysiological mechanisms leading to acute kidney injury in COVID-19 are unclear, but may include direct cytopathic effects of the virus on kidney tubular and endothelial cells, indirect damage caused by virus-induced cytokine release, and kidney hypoperfusion due to a restrictive fluid strategy. In this case-report we propose an additional pathophysiological mechanism. We describe two cases in which patients with COVID-19 developed a decrease in kidney function due to kidney infarction. These patients did not have atrial fibrillation. One of these patients was treated with therapeutic doses of low molecular weight heparin, whereafter no further deterioration of kidney function was observed. Our findings implicate that the differential diagnosis of acute kidney injury in COVID-19 patients should include kidney infarction, which may have important preventive and therapeutic implications."],"journal":"Am J Kidney Dis","authors":["Post, Adrian","den Deurwaarder, Edwin S G","Bakker, Stephan J L","de Haas, Robbert J","van Meurs, Matijs","Gansevoort, Ron T","Berger, Stefan P"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32479921","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1053/j.ajkd.2020.05.004","keywords":["acute kidney injury","covid-19","kidney infarction","sars-cov-2","anticoagulation"],"topics":["Case Report"],"weight":1,"_version_":1668437835022073857,"score":245.27058},{"pmid":32412303,"title":"Is the kidney a target of SARS-CoV-2?","text":["Is the kidney a target of SARS-CoV-2?","The new disease produced by the Severe Acute Respiratory Syndrome - coronavirus 2 (SARS-CoV-2) represents a major pandemic event nowadays. Since its origin in China in December 2019, there is compelling evidence that novel SARS-CoV-2 is a highly transmissible virus, and it is associated to a broad clinical spectrum going from subclinical presentation to severe respiratory distress and multi-organ failure. Like other coronaviruses, SARS-CoV-2 recognizes the human Angiotensin Converting Enzyme 2 (hACE2) as a cellular receptor that allows it to infect different host cells, and likely disrupts the renin-angiotensin-aldosterone system (RAAS) homeostasis. Particularly, it has been reported a considerable incidence of many renal abnormalities associated to COVID-19, including proteinuria, hematuria and acute kidney injury (AKI). Moreover, it has been recently demonstrated that SARS-CoV-2 can infect podocytes and tubular epithelial cells, which could contribute to the development of the aforementioned renal abnormalities. In this review, we discuss the biological aspects of the SARS-CoV-2 infection, how understanding current knowledge about SARS-CoV-2 infection may partly explain the involvement of the kidneys in the pathophysiology of COVID-19, and what questions arise and remain to be explored.","Am J Physiol Renal Physiol","Martinez-Rojas, Miguel A","Vega-Vega, Olynka","Bobadilla, Norma A","32412303"],"abstract":["The new disease produced by the Severe Acute Respiratory Syndrome - coronavirus 2 (SARS-CoV-2) represents a major pandemic event nowadays. Since its origin in China in December 2019, there is compelling evidence that novel SARS-CoV-2 is a highly transmissible virus, and it is associated to a broad clinical spectrum going from subclinical presentation to severe respiratory distress and multi-organ failure. Like other coronaviruses, SARS-CoV-2 recognizes the human Angiotensin Converting Enzyme 2 (hACE2) as a cellular receptor that allows it to infect different host cells, and likely disrupts the renin-angiotensin-aldosterone system (RAAS) homeostasis. Particularly, it has been reported a considerable incidence of many renal abnormalities associated to COVID-19, including proteinuria, hematuria and acute kidney injury (AKI). Moreover, it has been recently demonstrated that SARS-CoV-2 can infect podocytes and tubular epithelial cells, which could contribute to the development of the aforementioned renal abnormalities. In this review, we discuss the biological aspects of the SARS-CoV-2 infection, how understanding current knowledge about SARS-CoV-2 infection may partly explain the involvement of the kidneys in the pathophysiology of COVID-19, and what questions arise and remain to be explored."],"journal":"Am J Physiol Renal Physiol","authors":["Martinez-Rojas, Miguel A","Vega-Vega, Olynka","Bobadilla, Norma A"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32412303","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1152/ajprenal.00160.2020","keywords":["ace2","covid-19","raas","acute kidney injury","proteinuria"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Aldosterone"],"topics":["Mechanism"],"weight":1,"_version_":1666989866117758976,"score":223.17038},{"pmid":32418377,"title":"[Clinical analysis of kidney injury in patients with COVID-19].","text":["[Clinical analysis of kidney injury in patients with COVID-19].","Objective: To investigate the relationship between novel coronavirus pneumonia (COVID-19) and kidney injury. Methods: A retrospective analysis was performed on COVID-19 confirmed patients in the Central Theater Command General Hospital of Chinese PLA on March 12, 2020. A total of 87 hospitalized COVID-19 confirmed patients were enrolled in the study, and they were hospitalized at least one week. The recorded information included clinical data and indicators of kidney-related laboratory tests. Results: The average age of patients was (65.2+/-17.1) years, and 34.5% (30/87) patients were >/= 75 years old and 31.0% (27/87) patients were 60~74 years old. Male and female patients accounted for 59.8% (52/87) and 40.2% (35/87), respectively. There were 29.9% (26/87) and 12.6% (11/87) patients who had already showed mild elevation of blood urea nitrogen (BUN) and serum creatinine (SCr) at admission. Moreover, 25.3% (22/87) and 4.6% (4/87) patients still exhibited mild elevation of BUN and SCr one week after admission. However, 28.7% (25/87) patients showed an elevation of BUN one week later after admission, though their BUN levels were normal at admission. Likewise, 16.1% (14/87) patients showed an elevation of SCr one week later after admission, while their SCr levels were normal at admission. Only two patients had an increase of SCr >/=26.5 mumol/L, and both of them were over 75 years old. Conclusions: COVID-19 patients with severe acute kidney injury are uncommon. However, attention should be paid to acute kidney injury of the elderly patients in the diagnosis and treatment of COVID-19.","Zhonghua Yi Xue Za Zhi","Liu, Y","Qi, F Y","Wei, L","Cheng, Q L","32418377"],"abstract":["Objective: To investigate the relationship between novel coronavirus pneumonia (COVID-19) and kidney injury. Methods: A retrospective analysis was performed on COVID-19 confirmed patients in the Central Theater Command General Hospital of Chinese PLA on March 12, 2020. A total of 87 hospitalized COVID-19 confirmed patients were enrolled in the study, and they were hospitalized at least one week. The recorded information included clinical data and indicators of kidney-related laboratory tests. Results: The average age of patients was (65.2+/-17.1) years, and 34.5% (30/87) patients were >/= 75 years old and 31.0% (27/87) patients were 60~74 years old. Male and female patients accounted for 59.8% (52/87) and 40.2% (35/87), respectively. There were 29.9% (26/87) and 12.6% (11/87) patients who had already showed mild elevation of blood urea nitrogen (BUN) and serum creatinine (SCr) at admission. Moreover, 25.3% (22/87) and 4.6% (4/87) patients still exhibited mild elevation of BUN and SCr one week after admission. However, 28.7% (25/87) patients showed an elevation of BUN one week later after admission, though their BUN levels were normal at admission. Likewise, 16.1% (14/87) patients showed an elevation of SCr one week later after admission, while their SCr levels were normal at admission. Only two patients had an increase of SCr >/=26.5 mumol/L, and both of them were over 75 years old. Conclusions: COVID-19 patients with severe acute kidney injury are uncommon. However, attention should be paid to acute kidney injury of the elderly patients in the diagnosis and treatment of COVID-19."],"journal":"Zhonghua Yi Xue Za Zhi","authors":["Liu, Y","Qi, F Y","Wei, L","Cheng, Q L"],"date":"2020-05-18T11:00:00Z","year":2020,"_id":"32418377","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.3760/cma.j.cn112137-20200409-01143","keywords":["acute kidney injury","aged","blood urea nitrogen","covid-19"],"topics":["Diagnosis"],"weight":1,"_version_":1667058206825775105,"score":221.1567}]}